Creative Planning
GLSI icon

Creative Planning’s Greenwich LifeSciences GLSI Stock Holding History

Creative Planning’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-7,351
Closed -$251K – 2273
2021
Q1 		$251K Buy
7,351
+308
+4% +$10.5K ﹤0.01% 1908
2020
Q4 		$257K Buy
+7,043
New +$103K ﹤0.01% 1717

Other funds holding GLSI

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SW
SkyOak Wealth Southfield, Michigan $546M AUM 18.14% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Creative Planning's GLSI Position: Q2 2021 in Review

Creative Planning sold out of Greenwich LifeSciences (GLSI) in Q2 2021, closing a stake of 7,351 shares — an estimated $251K sold.

Creative Planning first reported a position in GLSI in Q4 2020 and held it in 2 quarters. The position peaked at $257K in Q4 2020. 30 funds tracked by Wall St. Rank hold GLSI as of Q2 2021.

  • Creative Planning reported no remaining Greenwich LifeSciences position as of Q2 2021 after selling out during the quarter.
  • Creative Planning sold 7,351 Greenwich LifeSciences shares in Q2 2021, an estimated $251K.
  • Creative Planning first reported a position in Greenwich LifeSciences in Q4 2020 and held it in 2 quarters.
  • Creative Planning's Greenwich LifeSciences position peaked at $257K in Q4 2020.
  • 30 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2021.

Based on Creative Planning's 13F filing for Q2 2021, filed 4 Aug 2021.